These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35236844)

  • 1. Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine-case report.
    Vnučák M; Graňák K; Beliančinová M; Jeseňák M; Macháleková KK; Benko J; Samoš M; Dedinská I
    NPJ Vaccines; 2022 Mar; 7(1):30. PubMed ID: 35236844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
    Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
    J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
    Ramasamy MN; Minassian AM; Ewer KJ; Flaxman AL; Folegatti PM; Owens DR; Voysey M; Aley PK; Angus B; Babbage G; Belij-Rammerstorfer S; Berry L; Bibi S; Bittaye M; Cathie K; Chappell H; Charlton S; Cicconi P; Clutterbuck EA; Colin-Jones R; Dold C; Emary KRW; Fedosyuk S; Fuskova M; Gbesemete D; Green C; Hallis B; Hou MM; Jenkin D; Joe CCD; Kelly EJ; Kerridge S; Lawrie AM; Lelliott A; Lwin MN; Makinson R; Marchevsky NG; Mujadidi Y; Munro APS; Pacurar M; Plested E; Rand J; Rawlinson T; Rhead S; Robinson H; Ritchie AJ; Ross-Russell AL; Saich S; Singh N; Smith CC; Snape MD; Song R; Tarrant R; Themistocleous Y; Thomas KM; Villafana TL; Warren SC; Watson MEE; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Faust SN; Pollard AJ;
    Lancet; 2021 Dec; 396(10267):1979-1993. PubMed ID: 33220855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis.
    Alhumaid S; Rabaan AA; Dhama K; Yong SJ; Nainu F; Hajissa K; Dossary NA; Alajmi KK; Saggar AEA; AlHarbi FA; Aswany MB; Alshayee AA; Alrabiah SA; Saleh AM; Alqarni MA; Gharib FMA; Qattan SN; Almusabeh HM; AlGhatm HY; Almoraihel SA; Alzuwaid AS; Albaqshi MA; Khalaf MAA; Albaqshi YA; Brahim AHA; Al Mutared MM; Al-Helal H; Alghazal HA; Al Mutair A
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.
    Costa Clemens SA; Jepson B; Bhorat QE; Ahmad A; Akhund T; Aley PK; Bansal H; Bibi S; Kelly EJ; Khan M; Lambe T; Lombaard JJ; Matthews S; Pipolo Milan E; Olsson U; Ramasamy MN; Moura de Oliveira Paiva MS; Seegobin S; Shoemaker K; Szylak A; Villafana T; Pollard AJ; Green JA;
    Lancet Microbe; 2024 Aug; 5(8):100863. PubMed ID: 38878794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Transplantation in Times of Covid-19: Decision Analysis in the Canadian Context.
    Yanev I; Gagnon M; Cheng MP; Paraskevas S; Kumar D; Dragomir A; Sapir-Pichhadze R
    Can J Kidney Health Dis; 2021; 8():20543581211040332. PubMed ID: 34540237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
    Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.
    Folegatti PM; Jenkin D; Morris S; Gilbert S; Kim D; Robertson JS; Smith ER; Martin E; Gurwith M; Chen RT;
    Vaccine; 2022 Aug; 40(35):5248-5262. PubMed ID: 35715352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
    Madhavan M; Ritchie AJ; Aboagye J; Jenkin D; Provstgaad-Morys S; Tarbet I; Woods D; Davies S; Baker M; Platt A; Flaxman A; Smith H; Belij-Rammerstorfer S; Wilkins D; Kelly EJ; Villafana T; Green JA; Poulton I; Lambe T; Hill AVS; Ewer KJ; Douglas AD
    EBioMedicine; 2022 Nov; 85():104298. PubMed ID: 36229342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients.
    Angelico R; Romano F; Coppola L; Materazzo M; Pedini D; Santicchia MS; Cacciola R; Toti L; Sarmati L; Tisone G
    Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138204
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
    Giannella M; Pierrotti LC; Helanterä I; Manuel O
    Transpl Int; 2021 Oct; 34(10):1776-1788. PubMed ID: 34450686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-Specific Antibodies, B Cell and T Cell Immune Responses after ChAdOx1 nCoV-19 Vaccination in Solid Organ Transplant Recipients.
    Phornkittikorn P; Kantachuvesiri S; Sobhonslidsuk A; Yingchoncharoen T; Kiertiburanakul S; Bruminhent J
    Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.
    Haase M; Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos-Araújo C; Veiga PM; Macario F
    J Nephrol; 2022 Jun; 35(5):1467-1478. PubMed ID: 35084719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveats of chimpanzee ChAdOx1 adenovirus-vectored vaccines to boost anti-SARS-CoV-2 protective immunity in mice.
    Cervantes-Torres J; Cabello-Gutiérrez C; Ayón-Núñez DA; Soldevila G; Olguin-Alor R; Diaz G; Acero G; Segura-Velázquez R; Huerta L; Gracia-Mora I; Cobos L; Pérez-Tapia M; Almagro JC; Suárez-Güemes F; Bobes RJ; Fragoso G; Sciutto E; Laclette JP
    Appl Microbiol Biotechnol; 2024 Jan; 108(1):179. PubMed ID: 38280035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial.
    Madhi SA; Kwatra G; Richardson SI; Koen AL; Baillie V; Cutland CL; Fairlie L; Padayachee SD; Dheda K; Barnabas SL; Bhorat QE; Briner C; Ahmed K; Aley PK; Bhikha S; Bhorat AE; Esmail A; Horne E; Kaldine H; Mukendi CK; Madzorera VS; Manamela NP; Masilela M; Hermanus ST; Motlou T; Mzindle N; Oelofse S; Patel F; Rhead S; Rossouw L; Taoushanis C; van Eck S; Lambe T; Gilbert SC; Pollard AJ; Moore PL; Izu A
    Lancet Infect Dis; 2023 Mar; 23(3):295-306. PubMed ID: 36273491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The humoral immune response to the BNT 162B2 vaccine in pediatrics on renal replacement therapy.
    Alshami A; Bahbah H; Al Attas R; Aldokhi F; Azzam A
    Pediatr Transplant; 2024 May; 28(3):e14712. PubMed ID: 38553800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis.
    Ling TC; Chen PL; Li NY; Ko WC; Sun CY; Chao JY; Shieh CC; Shen CF; Wu JL; Huang TC; Chao CH; Wang JR; Chang YT
    Microbiol Spectr; 2023 Feb; 11(2):e0344522. PubMed ID: 36809164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
    Kabbani D; Yotis DM; Ferreira VH; Shalhoub S; Belga S; Tyagi V; Ierullo M; Kulasingam V; Hébert MJ; West L; Delisle JS; Racine N; De Serres SA; Cardinal H; Dieudé M; Humar A; Kumar D
    Open Forum Infect Dis; 2023 May; 10(5):ofad200. PubMed ID: 37213422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.